Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001600620-24-000126
Filing Date
2024-11-25
Accepted
2024-11-25 16:38:58
Documents
1
Period of Report
2024-11-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1732570731.html 4  
1 FORM 4 wk-form4_1732570731.xml 4 5347
  Complete submission text file 0001600620-24-000126.txt   6781
Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Issuer) CIK: 0001600620 (see all company filings)

IRS No.: 981231763 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O JAZZ PHARMACEUTICALS PLC 5TH FL, WATERLOO EXCHANGE, WATERLOO RD DUBLIN L2 4 L2
Business Address
Smith Karen L. (Reporting) CIK: 0001639637 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36421 | Film No.: 241496504